ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK
43.65
08-يناير-25 16:45:00
15 متأخرة بدقائق
الأسهم
-0.79
-1.78%
نطاق اليوم
43.28 - 44.78
ISIN
N/A
المصدر
NASDAQ
-
Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference
28 فبراير 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
16 فبراير 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
09 فبراير 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
06 يناير 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 يناير 2023 06:00:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 ديسمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx to Present at Piper Sandler Healthcare Conference
22 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 نوفمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Announces Departure of Chief Financial Officer
10 نوفمبر 2022 16:15:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx to Present at Upcoming Healthcare Conferences
09 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update
02 نوفمبر 2022 16:05:01 بحسب Nasdaq GlobeNewswire
-
Ultragenyx to Host Conference Call for Third Quarter 2022 Financial Results and Corporate Update
27 أكتوبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04 أكتوبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR
09 سبتمبر 2022 20:22:15 بحسب Nasdaq GlobeNewswire
-
Ultragenyx to Participate at Citi BioPharma Conference
01 سبتمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17 أغسطس 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03 أغسطس 2022 16:05:02 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Reports Second Quarter 2022 Financial Results and Corporate Update
28 يوليو 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx to Host Conference Call for Second Quarter 2022 Financial Results and Corporate Update
25 يوليو 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 يوليو 2022 17:09:15 بحسب Nasdaq GlobeNewswire